TOP OF MEDICINE
Swiss Premium Doctors are the preferred supplier
of medical care for international patients
WELCOME
Your expert is at your disposal and
happy to assist you
PROF. DR. MED. S. RUSSMANN
Prof. Stefan Russmann, MD is an internationally distinguished drug safety specialist and expert in clinical pharmacology and toxicology.
TREATMENT FOCUS
Personalized check and optimization of the patient's current medication plan according to the latest scientific achievements and pharmacogenetic profile: |
|
Pharmacogenetic panel testing |
|
Check and adjustment of medication for your conditions |
|
Check of dose with adjustment for your kidney and liver function |
|
Identification of drug interactions for patients taking multiple drugs |
|
Optimal control of cardiovascular risk factors |
|
Blood pressure control with optional remote real time monitoring using the latest convenience technology |
|
Lowering of high cholesterol with latest convenience and safe drugs |
|
Prevention and evaluation of adverse drug reactions |
|
Evaluation and optimization of dietary supplements |
INTERNATIONAL EXPERIENCE
Adjunct Professor of Epidemiology at Boston University 2005-2021 (USA) |
|
Research Fellow with Boston Collaborative Drug Surveillance Program (BCDSP), USA (2004-2006) |
|
St. Mary's Hospital Medical School at Imperial College London |
|
Consulting senior physician at Hirslanden Hospital Zurich |
|
Medical studies at Albert-Ludwigs University Freiburg (GER) and St. Mary’s Hospital at Imperial College London (UK) |
MILESTONES / MEMBERSHIPS
Adjunct Professor of Clinical Pharmacology and Toxicology at University of Zurich |
|
Lecturer of Pharmacoepidemiology at ETH Zurich |
|
Author of more than 60 international leading research publications in the fields of clinical pharmacology, pharmacoepidemiology, drug safety, hepatotoxicity, gastroenterology, nephrology, cardiology and pharmacogenetics |
TOP-LEVEL THERAPY
State-of-the-art pharmacotherapy, prevention of drug interactions and adverse drug reactions |
|
Pharmacological prevention and treatment of cardiovascular and cerebrovascular diseases (including myocardial infarction and stroke) |
|
Toxic liver disease |
|
Autosomal dominant polycystic kidney disease (ADPKD): Latest treatment options for delay of disease progression (in collaboration with nephrologist) |
|
Irritable bowel syndrome: consultation on personalized diet, dietary supplements and medication |
|
Pharmacogenetics: genetic testing with personalized adjustment of medication based on your individual pharmacogenetic profile |
WELCOME
Your expert is at your disposal and happy to assist you
PROF. DR. MED. S. RUSSMANN
Prof. Stefan Russmann, MD is an internationally distinguished drug safety specialist and expert in clinical pharmacology and toxicology.
TREATMENT FOCUS
Personalized check and optimization of the patient's current medication plan according to the latest scientific achievements and pharmacogenetic profile: |
|
Pharmacogenetic panel testing |
|
Check and adjustment of medication for your conditions |
|
Check of dose with adjustment for your kidney and liver function |
|
Identification of drug interactions for patients taking multiple drugs |
|
Optimal control of cardiovascular risk factors |
|
Blood pressure control with optional remote real time monitoring using the latest convenience technology |
|
Lowering of high cholesterol with latest convenience and safe drugs |
|
Prevention and evaluation of adverse drug reactions |
|
Evaluation and optimization of dietary supplements |
INTERNATIONAL EXPERIENCE
Adjunct Professor of Epidemiology at Boston University 2005-2021 (USA) |
|
Research Fellow with Boston Collaborative Drug Surveillance Program (BCDSP), USA (2004-2006) |
|
St. Mary's Hospital Medical School at Imperial College London |
|
Consulting senior physician at Hirslanden Hospital Zurich |
|
Medical studies at Albert-Ludwigs University Freiburg (GER) and St. Mary’s Hospital at Imperial College London (UK) |
MILESTONES / MEMBERSHIPS
Adjunct Professor of Clinical Pharmacology and Toxicology at University of Zurich |
|
Lecturer of Pharmacoepidemiology at ETH Zurich |
|
Author of more than 60 international leading research publications in the fields of clinical pharmacology, pharmacoepidemiology, drug safety, hepatotoxicity, gastroenterology, nephrology, cardiology and pharmacogenetics |
TOP-LEVEL THERAPY
State-of-the-art pharmacotherapy, prevention of drug interactions and adverse drug reactions |
|
Pharmacological prevention and treatment of cardiovascular and cerebrovascular diseases (including myocardial infarction and stroke) |
|
Toxic liver disease |
|
Autosomal dominant polycystic kidney disease (ADPKD): Latest treatment options for delay of disease progression (in collaboration with nephrologist) |
|
Irritable bowel syndrome: consultation on personalized diet, dietary supplements and medication |
|
Pharmacogenetics: genetic testing with personalized adjustment of medication based on your individual pharmacogenetic profile |
BOOK NOW
BOOK NOW
